{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-23-000334","form_type":"8-K","ticker":"CCRN","cik":"0001141103","company_name":"CROSS COUNTRY HEALTHCARE INC","filed_at":"2023-02-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.974664+00:00","generated_at":"2026-06-19T04:13:45.711251+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cross Country Healthcare Q4 revenue down 2% YoY; guides Q1 revenue down ~25% YoY","bullets":["Q4 revenue $628.2M (-2% YoY); net income $38.8M (-50% YoY); diluted EPS $1.05 vs $2.07.","Full year 2022 revenue $2.8B (+67% YoY); net income $188.5M (+43% YoY); adjusted EBITDA $301.7M (+86%).","Q1 2023 guidance: revenue $590-600M (down ~25% YoY); adjusted EBITDA $44-49M (down ~50% YoY).","Completed acquisitions of Mint, Lotus, and HireUp in Q4; repurchased 0.4M shares for $10.9M.","Made $100M optional prepayments on term loan in 2022; remaining $76.2M share repurchase authorization."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-23-000334","json":"https://secwatch.observer/filing/0001157523-23-000334.json","markdown":"https://secwatch.observer/filing/0001157523-23-000334.md","text":"https://secwatch.observer/filing/0001157523-23-000334.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1141103/000115752323000334/0001157523-23-000334-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1141103/000115752323000334/a53334950.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T04:13:45.711251+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2c0f119146c26a9dd24757bb7364eabde07877cc","claim":"CROSS COUNTRY HEALTHCARE INC reported the full year ended December 31, 2022 results: revenue $2.8 billion, net income $188.5 million, EPS 5.02.","evidence_excerpt":"For the year ended December 31, 2022, consolidated revenue was $2.8 billion, an increase of 67% year-over-year. Consolidated gross profit margin was 22.4%, consistent with the prior year. Net income attributable to common stockholders was $188.5 million, or 5.02 per diluted share, compared to $132.0 million, or $3.53 per diluted share, in the prior year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1141103/000115752323000334/0001157523-23-000334-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year ended December 31, 2022"},{"label":"Revenue","value":"$2.8 billion"},{"label":"Net income","value":"$188.5 million"},{"label":"EPS","value":"5.02"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"e2b576ed568527c44ce03832b87ad2787b1aec3c","claim":"CROSS COUNTRY HEALTHCARE INC reported the fourth quarter ended December 31, 2022 results: revenue $628.2 million, net income $38.8 million, EPS $1.05.","evidence_excerpt":"Fourth quarter consolidated revenue was $628.2 million, a slight decrease from the prior year and prior quarter. Consolidated gross profit margin was 22.1%, down 90 basis points year-over-year and 50 basis points sequentially. Net income attributable to common stockholders was $38.8 million compared to $77.6 million in the prior year and $34.8 million in the prior quarter. Diluted earnings per share (EPS) was $1.05 compared to $2.07 in the prior year and $0.93 in the prior quarter.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1141103/000115752323000334/0001157523-23-000334-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2022"},{"label":"Revenue","value":"$628.2 million"},{"label":"Net income","value":"$38.8 million"},{"label":"EPS","value":"$1.05"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}